ResearchMoz

Gastric Cancer Market Research Reports & Industry Analysis

Gastric cancer and esophageal cancer is a type of orphan cancer that occurs in the gastrointestinal tract. Due to a late onset of symptoms, these two cancers are often diagnosed at an advanced, almost incurable stage. However, they are still related to lesser survival rates in the early stages of disease. 
According to research analysts, the global gastric cancer therapeutics market is growing. This increase is witnessed due to the rise in growth factor in terms of patients receiving gastric cancer therapy. It is also because the annual cost of therapy and medicines has increased in the pharmaceutical industry. All these value-driven factors are incessantly anticipating the market size, growth, and forecast period of this industry.     
As per the statistics, the patient volume is mainly driven by an increase in the number of patients in countries such as Spain, Italy, France, and especially China. The incidences of gastric cancer in China are witnessed to be one of the highest across the globe, surpassing Japan and Korea, where the incident cases have increased 1.6 percent annually in China between 2010 and 2015. China and Japan lead the market due to a vast patient base in gastric cancer.  
Gastric cancer has no standard care and the treatment of this cancer is typically based on different treatment guidelines followed in various countries. There are very few drugs that are truly approved for gastric cancer and currently the primary treatment options in this field are surgery and chemotherapy, which are used wherever possible.  
ResearchMoz gastric cancer reports provide every elemental detail and information relating to the gastric cancer and clinical trials, trial status, briefing pertaining to the numbers of trials for key drugs, and more. Our reports are worth the purchase because every report elaborates the dynamics of a particular indication in a comprehensive and condensed manner. Browse through the updated collection of gastric cancer reports on ResearchMoz that consists of all the analysis and valuable insights into the global gastric cancer therapeutics market. 

Gastric Cancer

Browse reports in Gastric Cancer

Displaying 1 to 16 (of 16 records)
Dysphagia Global Clinical Trials Review, H1, 2013
Apr 2013   |   By - GlobalData
Dysphagia Global Clinical Trials Review, H1, 2013 Summary GlobalData's clinical trial report, Dysphagia Global Clinical Trials Review, H1, 2013" provides data on the Dysphagia clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Dysphagia. It includes an overview of the trial numbers and their recruitment...
$2500
Tesetaxel (Gastric Cancer) Analysis and Forecasts to 2020
Oct 2011   |   By - GlobalData
Summary GlobalDatas pharmaceuticals report, Tesetaxel (Gastric Cancer) Analysis and Forecasts to 2020 provides Tesetaxel sales forecasts for US, EU5 and Japan. In addition, it covers detailed clinical assessment of the drug, factors impacting drug sales, competitive landscape, and analysis of sales performance during the forecast period (2014-2020). The report also includes information...
$2000
Herceptin (Gastric Cancer) -Analysis and Forecasts to 2020
Oct 2011   |   By - GlobalData
GlobalDatas pharmaceuticals report, Herceptin (Gastric Cancer)-Analysis and Forecasts to 2020 provides Herceptin sales estimates for US, EU5 and Japan. In addition, it covers detailed clinical assessment of the drug, factors impacting drug sales, competitive landscape, and analysis of sales performance during the forecast period (2010-2020). The report also includes information on Oncology's...
$2000
Tykerb (Gastric Cancer) - Analysis and Forecasts to 2020
Oct 2011   |   By - GlobalData
GlobalDatas pharmaceuticals report, Tykerb (Gastric Cancer) - Analysis and Forecasts from 2012 to 2020 provides Tykerb sales estimates for US, EU5 and Japan. In addition, it covers detailed clinical assessment of the drug, factors impacting drug sales, competitive landscape, and analysis of sales performance during the forecast period (2012-2020). The report also includes information on...
$2000
S-1 (Gastric Cancer) - Analysis and Forecasts to 2020
Oct 2011   |   By - GlobalData
GlobalDatas pharmaceuticals report, S-1 (Gastric Cancer) - Analysis and Forecasts to 2020 provides S-1 sales estimates for EU5 and Japan. In addition, it covers detailed clinical assessment of the drug, factors impacting drug sales, competitive landscape, and analysis of sales performance during the forecast period (2002-2020). The report also includes information on Oncology's Disease...
$2000
Xeloda (Gastric Cancer)- Analysis and Forecasts to 2020
Oct 2011   |   By - GlobalData
GlobalDatas pharmaceuticals report, Xeloda (Gastric Cancer)- Analysis and Forecasts to 2020 provides Xeloda sales estimates for US, EU5 and Japan. In addition, it covers detailed clinical assessment of the drug, factors impacting drug sales, competitive landscape, and analysis of sales performance during the forecast period (2007-2020). The report also includes information on Oncology's...
$2000
Etoposide (Gastric Cancer) - Analysis and Forecasts to 2020
Oct 2011   |   By - GlobalData
GlobalDatas pharmaceuticals report, Etoposide (Gastric Cancer) - Analysis and Forecasts to 2020 provides Etoposide sales estimates for US, EU5 and Japan. In addition, it covers detailed clinical assessment of the drug, factors impacting drug sales, competitive landscape, and analysis of sales performance during the forecast period (2002-2020). The report also includes information on Oncology's...
$2000
Afinitor (Gastric Cancer) - Analysis and Forecasts to 2020
Oct 2011   |   By - GlobalData
GlobalDatas pharmaceuticals report, Afinitor (Gastric Cancer) - Analysis and Forecasts to 2020 provides Afinitor sales forecasts for US, EU5 and Japan. In addition, it covers detailed clinical assessment of the drug, factors impacting drug sales, competitive landscape, and analysis of sales performance during the forecast period (2013-2020). The report also includes information on Oncology's...
$2000
Ramucirumab (Gastric Cancer) - Analysis and Forecast to 2020
Oct 2011   |   By - GlobalData
GlobalDatas pharmaceuticals report, Ramucirumab (Gastric Cancer) - Analysis and Forecast to 2020 provides Ramucirumab sales forecasts for US, and EU-5. In addition, it covers detailed clinical assessment of the drug, factors impacting drug sales, competitive landscape, and analysis of sales performance during the forecast period (2014-2020). The report also includes information on Oncology's...
$2000
Cisplatin (Gastric Cancer) - Analysis and Forecasts to 2020
Oct 2011   |   By - GlobalData
GlobalDatas pharmaceuticals report, Cisplatin (Gastric Cancer) Analysis and Forecasts to 2020 provides Cisplatin sales estimates for US, EU5 and Japan. In addition, it covers detailed clinical assessment of the drug, factors impacting drug sales, competitive landscape, and analysis of sales performance during the forecast period (2002-2020). The report also includes information on Oncology's...
$2000
Doxorubicin (Gastric Cancer) - Analysis and Forecast to 2020
Oct 2011   |   By - GlobalData
GlobalDatas pharmaceuticals report, Doxorubicin (Gastric Cancer) - Analysis and Forecast to 2020 provides Doxorubicin estimates for US, EU5 and Japan. In addition, it covers detailed clinical assessment of the drug, factors impacting drug sales, competitive landscape, and analysis of sales performance during the forecast period (2002-2020). The report also includes information on Oncology's...
$2000
Ellence (Gastric Cancer) - Analysis and Forecasts to 2020
Oct 2011   |   By - GlobalData
GlobalDatas pharmaceuticals report, Ellence (Gastric Cancer) - Analysis and Forecasts to 2020 provides Ellence sales estimates for EU5 . In addition, it covers detailed clinical assessment of the drug, factors impacting drug sales, competitive landscape, and analysis of sales performance during the forecast period (2002-2012). The report also includes information on Oncology's Disease...
$2000
Erbitux (Gastric Cancer)- Analysis and Forecasts to 2020
Oct 2011   |   By - GlobalData
GlobalDatas pharmaceuticals report, Erbitux (Gastric Cancer)- Analysis and Forecasts to 2020 provides Erbitux sales forecasts for US and EU5. In addition, it covers detailed clinical assessment of the drug, factors impacting drug sales, competitive landscape, and analysis of sales performance during the forecast period (2014-2020). The report also includes information on Oncology's Disease...
$2000
Mitomycin (Gastric Cancer) - Analysis and Forecasts to 2020
Oct 2011   |   By - GlobalData
GlobalDatas pharmaceuticals report, Mitomycin (Gastric Cancer) - Analysis and Forecasts to 2020 provides Mitomycin sales estimates for US, EU5 and Japan. In addition, it covers detailed clinical assessment of the drug, factors impacting drug sales, competitive landscape, and analysis of sales performance during the forecast period (2002-2020). The report also includes information on...
$2000
Taxotere (Gastric Cancer) - Analysis and Forecasts to 2020
Oct 2011   |   By - GlobalData
GlobalDatas pharmaceuticals report, Taxotere (Gastric Cancer) - Analysis and Forecasts to 2020 provides Taxotere sales estimates for US, EU5 and Japan . In addition, it covers detailed clinical assessment of the drug, factors impacting drug sales, competitive landscape, and analysis of sales performance during the forecast period (2002-2020). The report also includes information on Oncology's...
$2000
Vectibix (Gastric Cancer) - Analysis and Forecasts to 2020
Oct 2011   |   By - GlobalData
GlobalDatas pharmaceuticals report, Vectibix (Gastric Cancer) - Analysis and Forecasts to 2020 provides Vectibix sales forecasts for US, EU5 and Japan. In addition, it covers detailed clinical assessment of the drug, factors impacting drug sales, competitive landscape, and analysis of sales performance during the forecast period (2014-2020). The report also includes information on...
$2000
 
Displaying 1 to 16 (of 16 records)

Research Assistance

We will be happy to help you find what you need.
Please call us or write us:

866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-618-1030
Email: sales@researchmoz.com

Popular Publishers

Transparency Market Research
ICD Research
Technavio
 
GBI Research
Winter Green Research
GlobalData